SpyGlass Pharma, Inc. (SGP)

SpyGlass Pharma, Inc. (SGP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $792M; returns 1 day +0.9%, 1 week +18.7%.

SpyGlass Pharma, Inc. (SGP) is a late-stage biopharmaceutical company focused on sustained-release drug delivery systems for chronic ophthalmic conditions. The company's business model centers on its proprietary SpyGlass Drug Delivery Platform, which integrates drug-eluting pads into a standard intraocular lens (IOL).

Groups SGP belongs to

• Recent IPOs
• Ophthalmology
• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Life Sciences
• Medical Devices
• Healthcare
• Clinical Stage
• Drug Discovery

SGP financial model: income statement, cash flow and balance sheet